A K Pharmascope Limited - Limited company - abbreviated - 11.6

REGISTERED NUMBER: 06579614 (England and Wales)

Abbreviated Accounts For The Year Ended 30 April 2014

for

A K Pharmascope Limited

Page

Company Information

1

Abbreviated Balance Sheet

2

Notes to the Abbreviated Accounts

4

Chartered Certified Accountants' Report

5

DIRECTORS:

Mr A K Tataria

Mr A R Tataria

SECRETARY:

Mr A R Tataria

REGISTERED OFFICE:

86 Mount Road

Leicester

LE5 3DJ

REGISTERED NUMBER:

06579614 (England and Wales)

ACCOUNTANTS:

Gower Accountancy

Chartered Certified Accountants

250 Humberstone Road

Leicester

Leicestershire

LE5 0EG

FIXED ASSETS

Tangible assets

2

2

2

CURRENT ASSETS

Debtors

3,540

1,396

Cash at bank

33,789

36,150

37,329

37,546

CREDITORS

Amounts falling due within one year

(36,464

)

(37,314

)

NET CURRENT ASSETS

865

232

TOTAL ASSETS LESS CURRENT LIABILITIES

867

234

CAPITAL AND RESERVES

Called up share capital

3

2

2

Profit and loss account

865

232

SHAREHOLDERS' FUNDS

867

234

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 April 2014.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 April 2014 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The abbreviated accounts have been prepared in accordance with the special provisions of Part 15 of the Companies Act 2006 relating to small companies.

The financial statements were approved by the Board of Directors on 9 January 2015 and were signed on its behalf by:

Mr A K Tataria - Director

1.	ACCOUNTING POLICIES

Accounting convention

The financial statements have been prepared under the historical cost convention and in accordance with the

Financial Reporting Standard for Smaller Entities (effective April 2008).

Turnover

Turnover represents net invoiced sales of goods, excluding value added tax.

Tangible fixed assets

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Fixtures and fittings

-

25% on cost

Computer equipment

-

33.3% on cost

Deferred tax

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance

sheet date.

2.	TANGIBLE FIXED ASSETS

Total

£

COST

At 1 May 2013

and 30 April 2014

5,310

DEPRECIATION

At 1 May 2013

and 30 April 2014

5,308

NET BOOK VALUE

At 30 April 2014

2

At 30 April 2013

2

3.	CALLED UP SHARE CAPITAL

Allotted and issued:

Number:

Class:

Nominal

2014

2013

value:

£

£

2

Ordinary

£1

2

2

The following reproduces the text of the report prepared for the directors in respect of the company's annual

unaudited financial statements, from which the unaudited abbreviated accounts (set out on pages two to four)

have been prepared.

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the

financial statements of A K Pharmascope Limited for the year ended 30 April 2014 which comprise the Profit and Loss

Account, the Balance Sheet, and the related notes from the company's accounting records and from information and

explanations you have given us.

As a practising member firm of the Association of Chartered Certified Accountants, we are subject to its ethical and

other professional requirements which are detailed at http://rulebook.accaglobal.com.

This report is made solely to the Board of Directors of A K Pharmascope Limited, as a body, in accordance with our

terms of engagement. Our work has been undertaken solely to prepare for your approval the financial statements of A K

Pharmascope Limited and state those matters that we have agreed to state to the Board of Directors of A K Pharmascope

Limited, as a body, in this report in accordance with the requirements of the Association of Chartered Certified

Accountants as detailed at http://www.accaglobal.com/factsheet163. To the fullest extent permitted by law, we do not

accept or assume responsibility to anyone other than the company and its Board of Directors, as a body, for our work or

for this report.

It is your duty to ensure that A K Pharmascope Limited has kept adequate accounting records and to prepare statutory

financial statements that give a true and fair view of the assets, liabilities, financial position and profit of A K

Pharmascope Limited. You consider that A K Pharmascope Limited is exempt from the statutory audit requirement for

the year.

We have not been instructed to carry out an audit or a review of the financial statements of A K Pharmascope Limited.

For this reason, we have not verified the accuracy or completeness of the accounting records or information and

explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.

Gower Accountancy

Chartered Certified Accountants

250 Humberstone Road

Leicester

Leicestershire

LE5 0EG

9 January 2015